Skip to Content

Corporate Restructuring and Bankruptcy

Overview
Garfunkel Wild’s Corporate Restructuring and Bankruptcy Practice Group has represented key constituents in many of the healthcare sector’s largest and most complex reorganizations, including the Debtor representation of multiple hospital systems as well as one of the largest not-for-profit social services agency to ever navigate the chapter 11 process.  Our attorneys in this Group pride themselves on developing practical and innovative solutions to the complex and unique issues which often arise when a healthcare provider is faced with financial extremis.  Our expertise goes well beyond the healthcare and not-for-profit sectors, however, and our attorneys have broad experience working with sizeable businesses in the real estate, manufacturing, service, technology, and retail sectors as they restructure their affairs either informally or in the context of Chapter 11 of the Bankruptcy Code. 
 
The Corporate Restructuring and Bankruptcy Practice Group advises our clients in the following representative areas:
 
  • Preparing and prosecuting Chapter 11 cases for corporate debtors including not-for-profit hospitals and other institutions
  • Providing advice and assistance with asset acquisitions, claims trading, exempt property and asset protection issues, and enforcement of shareholders’ and creditors’ rights
  • Developing competing plans of reorganization for potential acquirers of distressed entities
  • Obtaining debtor-in-possession financing
  • Defending against preference and fraudulent conveyance actions
  • Advising about general business practices for debtors-in-possession and troubled companies
  • Defending against and assisting with involuntary bankruptcies
 
In addition to working directly with debtors and other troubled companies, the Group has represented numerous creditors’ committees, individual creditors, and creditor constituencies in many complex and highly visible Chapter 11 cases. We also provide advice on distressed lending and all phases of distressed mergers and acquisitions, including stock and asset acquisitions of financially distressed companies.